Clinical trials
Fibrosis trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 6 |
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Terminated | 12 |
| Recruiting | 9 |
| Unknown status | 4 |
| Active, not recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gilead Sciences | 7 |
| Intercept Pharmaceuticals | 4 |
| Genfit | 3 |
| Novartis Pharmaceuticals | 3 |
| Vertex Pharmaceuticals Incorporated | 3 |
| 89bio, Inc. | 2 |
| AbbVie | 2 |
| Inventiva Pharma | 2 |
| RWTH Aachen University | 2 |
| University Hospital Muenster | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fibrosis | 61 |
| Non-alcoholic Fatty Liver Disease | 13 |
| Liver Cirrhosis | 11 |
| Liver Diseases | 9 |
| Hepatitis C | 8 |
| Fatty Liver | 6 |
| Digestive System Diseases | 5 |
| Lung Diseases | 5 |
| Liver Cirrhosis, Biliary | 4 |
| Lung Diseases, Interstitial | 4 |
Trials
Showing 76 to 61 of 61. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.